comparemela.com

Latest Breaking News On - Advanced therapeutics center - Page 1 : comparemela.com

Protara Therapeutics (TARA) Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC

Protara Therapeutics (TARA) Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Florida
United-states
Timothy-lyon
Jesse-shefferman
Gautam-jayram
Therapeutics-center
Clinical-program
Protara-therapeutics-inc
Nasdaq
Urology-residency-program
Urology-associates
Protara-therapeutics

Protara Therapeutics Announces Positive Three-Month Data From TARA-002 Clinical Program In NMIBC

Protara Therapeutics Announces Positive Three-Month Data From TARA-002 Clinical Program In NMIBC
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Florida
United-states
Taiwan
Germany
Japan
German
Gautam-jayram
Justine-omalley
Jesse-shefferman
Klinische-einheit
Timothy-lyon
Drug-administration

Engage in Social Media, But Do So Carefully - Renal and Urology News

Urology practices can leverage social media for patient outreach, education, and advertising. Urology practices should embrace social media for patient outreach, education, and advertising, but avoid violating HIPAA private rules.

Maryland
United-states
Tennessee
Nashville
Davids-morris
Kari-bailey
Large-urology-group-practice-association
Instagram
Youtube
Forward-committee
Therapeutics-center-at-urology-associates-in-nashville
Facebook

Dr Morris on Active Surveillance in Low- and Intermediate-Risk Patients With Prostate Cancer

David Morris, MD, FACS, discusses the best practices for active surveillance in low- and intermediate-risk patients with prostate cancer, highlighting factors to look for in patients undergoing active surveillance that may point to the need for further treatment.

David-morris
Morris
Urology-associates-of-nashville
Therapeutics-center
Advanced-therapeutics-center
Urology-associates
Onclive-tv
Prostate-cancer
Lugpa-annual-meeting

Successful Bladder Cancer Programs Rely on Old Pillars, New Innovations

Building a successful bladder cancer program requires clinicians to employ a multifaceted approach that prioritizes good surgical practices, embraces immunotherapies with an understanding of the adverse effects that can accompany them, and being up to date in terms of options for patients.

Tennessee
United-states
San-antonio
Texas
Vanderbilt-university
Tom-jayram
Daniel-saltzstein
Therapeutics-center-at-urology-associates
Vanderbilt-university-in-nashville
Advanced-therapeutics-center
Urology-associates
Urology-san-antonio

vimarsana © 2020. All Rights Reserved.